LAL-D is under-diagnosed¹

LAL-D primarily presents in pediatric patients, however, many older patients with LAL-D may be misdiagnosed or undiagnosed²

PATIENTS WITH LAL-D MAY PRESENT AT ANY AGE²

Image adapted from Bernstein DL, et al. J Hepatol. 2013;58(6):1230-1243.

^aThis observational study included 48 patients with confirmed diagnosis of LAL-D from North America and Europe. Patients with rapidly progressive LAL-D ≤5 years of age were excluded from the study.

LAL-D IS RARE, WITH AN ESTIMATED PREVALENCE OF

Abbreviation: LAL-D, lysosomal acid lipase deficiency.

Note: The estimated mean birth prevalence of rapidly progressive LAL-D was 0.32-1.1 cases per million births in the European ancestry population, and the mean birth prevalence of childhood/adult LAL-D was 3.45-5.97 cases per million births (Del Angel et al. 2019).

References: 1. Reiner Ž, et al. Atherosclerosis. 2014;235(1):21-30. 2. Bernstein DL, et al. J Hepatol. 2013;58(6):1230-1243. 3. del Angel G, et al. Hum Mutat. 2019;40:2007-2020. 4. Lukacs Z, et al. Clinica Chimica Acta. 2017;471:201-205.

Test for LAL-D with a simple blood test that includes a blood draw^1,4

Learn more about testing

REGISTER TODAY
and receive all the latest LAL-D information.

*All fields are required

By clicking Submit, I agree to the Terms of Use

LAL-D is under-diagnosed1

LAL-D primarily presents in pediatric patients, however, many older patients with LAL-D may be misdiagnosed or undiagnosed2

PATIENTS WITH LAL-D MAY PRESENT AT ANY AGE2